What are the major opportunities in the Viral Gastroenteritis market? What are the strategies for the Viral Gastroenteritis market?

For detailed insights on the major opportunities and strategies in the Viral Gastroenteritis market, Read More

How does the Viral Gastroenteritis market relate to the overall economy and other similar markets?

For detailed insights on Viral Gastroenteritis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Viral Gastroenteritis market growth? SWOT analysis of the Viral Gastroenteritis market.

For detailed insights on the key dynamics influencing the Viral Gastroenteritis market growth and SWOT analysis of the Viral Gastroenteritis industry, Read More

Viral Gastroenteritis Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Viral Gastroenteritis Market Report 2026

Name: Viral Gastroenteritis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drugs (Antibiotics, Antacids, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdominal Cramps, Pain, Other Indications), By Type Of Virus (Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus), By End User (Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Viral Gastroenteritis Market Overview

• Viral Gastroenteritis market size has reached to $7.06 billion in 2025

• Expected to grow to $9.2 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%

• Growth Driver: Rising Prevalence Of Gastrointestinal Disorders To Drive Market Growth

• Market Trend: Innovative PCR Kits Reshaping The Viral Gastroenteritis Market

• North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Viral Gastroenteritis Market?

Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

The main types of drugs in viral gastroenteritis are antibiotics, antacids, laxatives, antimotility agents, and others. Antacids refer to medicines that neutralize the acid in the stomach to relieve heartburn and indigestion. The various diagnosis includes a physical examination and a rapid stool test that is indicated by various indications such as watery diarrhea, abdominal cramps, pain, and others. The various types of viruses include norovirus, rotavirus, astrovirus, and enteric adenovirus. These are used by various end-users such as hospitals, clinics, pharmaceutical companies, diagnostic centers, ambulatory care centers, and others.

Viral Gastroenteritis Market Global Report 2026 Market Report bar graph

What Is The Viral Gastroenteritis Market Size and Share 2026?

The viral gastroenteritis market size has grown strongly in recent years. It will grow from $7.06 billion in 2025 to $7.43 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to improvements in public health awareness, expansion of healthcare access, availability of basic diagnostic tools, increasing use of oral rehydration solutions, improved disease reporting systems.

What Is The Viral Gastroenteritis Market Growth Forecast?

The viral gastroenteritis market size is expected to see strong growth in the next few years. It will grow to $9.2 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing investments in infectious disease surveillance, rising demand for rapid point-of-care diagnostics, expansion of vaccination and prevention programs, growing focus on pediatric healthcare, increasing adoption of digital disease monitoring. Major trends in the forecast period include increasing focus on rapid diagnostic testing, rising demand for supportive care therapies, growing emphasis on infection control and prevention, expansion of oral rehydration and zinc therapy usage, enhanced surveillance of viral outbreaks.

Book your 30 minutes free consultation with our research experts

Global Viral Gastroenteritis Market Segmentation

1) By Drugs: Antibiotics, Antacids, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

3) By Antimotility Agents: Loperamide, Diphenoxylate

4) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

What Is The Driver Of The Viral Gastroenteritis Market?

The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the viral gastroenteritis market going forward. Gastrointestinal (GI) disorders refer to a disease that occurs within or on any part of the gastrointestinal tract. Viral gastroenteritis drugs and diagnosis treatments help people suffering from the illness with proper and appropriate medication. For instance, in September 2023, according to the Impact of IBD Report 2023 published by the IBD Clinical and Research Centre, a Canada-based organization that aims to improve the lives of patients with Crohn's disease and ulcerative colitis, with a prevalence of 825 per 100,000 in 2023, over 320,000 people in Canada have inflammatory bowel disease (IBD), and as the prevalence is expected to increase by 2.44% annually, 1.1% of the population, or 470,000 Canadians, is projected to be living with IBD by 2035. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the viral gastroenteritis industry.

Key Players In The Global Viral Gastroenteritis Market

Major companies operating in the viral gastroenteritis market are Pfizer Inc., Sanofi S A, Abbott Laboratories, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Mylan N V, Dr Reddys Laboratories Ltd, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, ANI Pharmaceuticals Inc, Merck Sharp & Dohme Corp, Abbvie Inc, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Roche Holding AG, BristolMyersSquibb Company, Amgen Inc, Eli Lilly and Company, Novartis AG, Johnson and Johnson, Moderna Inc, Bharat Biotech International Ltd

Global Viral Gastroenteritis Market Trends and Insights

Major companies operating in the viral gastroenteritis market are developing new products such as PCR kits for gastrointestinal infectious diseases to gain a competitive edge in the market. PCR kits, or Polymerase Chain Reaction kits, are molecular biology tools designed for the amplification and detection of specific DNA sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based molecular diagnostic solutions company, launched 10 Real-Time PCR Kits designed for accurate detection of gastrointestinal pathogens, forming a comprehensive Total PCR Solution when integrated with their extraction solution and PCR system. The Real-Time PCR Kits cover a range of bacterial, viral, and parasitic pathogens associated with gastrointestinal infections. These include diseases caused by various bacterial pathogens such as Campylobacter, Salmonella, Shigella, and Clostridioides difficile, as well as viral agents like Adenovirus, Rotavirus, Astrovirus, and Norovirus. This innovative solution provides a streamlined approach from sample pre-processing to PCR amplification analysis.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Viral Gastroenteritis Market?

In January 2024, HilleVax Inc., a Switzerland-based biotech company, collaborated with Chengdu Kanghua Biological Products Co. Ltd. Through this collaboration, HilleVax Inc. aims to develop HIL-216, a next-generation norovirus vaccine that targets six common genotypes, with clinical trials set to begin in 2024 following FDA clearance. Kanghua Biological Products Co. Ltd. is a China-based firm focused on developing and manufacturing biological products and vaccines for veterinary and human health.

Regional Outlook

North America was the largest region in the viral gastroenteritis market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Gastroenteritis Market?

The viral gastroenteritis market consists of revenues earned by entities by providing various diagnostics such as polymerase chain reaction testing and immunoassays. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral gastroenteritis market also includes sales of antiemetics, and chemotherapy drugs used for treating viral gastroenteritis. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viral Gastroenteritis Market Report 2026?

The viral gastroenteritis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral gastroenteritis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Viral Gastroenteritis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$7.43 billion
Revenue Forecast In 2035	$9.2 billion
Growth Rate	CAGR of 5.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drugs, Diagnosis, Indication, Type Of Virus, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Sanofi S A, Abbott Laboratories, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Mylan N V, Dr Reddys Laboratories Ltd, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, ANI Pharmaceuticals Inc, Merck Sharp & Dohme Corp, Abbvie Inc, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Roche Holding AG, BristolMyersSquibb Company, Amgen Inc, Eli Lilly and Company, Novartis AG, Johnson and Johnson, Moderna Inc, Bharat Biotech International Ltd
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Viral Gastroenteritis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Viral Gastroenteritis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Viral Gastroenteritis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Viral Gastroenteritis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Focus On Rapid Diagnostic Testing

4.2.2 Rising Demand For Supportive Care Therapies

4.2.3 Growing Emphasis On Infection Control And Prevention

4.2.4 Expansion Of Oral Rehydration And Zinc Therapy Usage

4.2.5 Enhanced Surveillance Of Viral Outbreaks

5. Viral Gastroenteritis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Diagnostic Centers

5.4 Pharmaceutical Companies

5.5 Ambulatory Care Centers

6. Viral Gastroenteritis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Viral Gastroenteritis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Viral Gastroenteritis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Viral Gastroenteritis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Viral Gastroenteritis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Viral Gastroenteritis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Viral Gastroenteritis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Viral Gastroenteritis Market Segmentation

9.1. Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antibiotics, Antacids, Antimotility Agents, Others Drugs

9.2. Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Physical Examination, Rapid Stool Test

9.3. Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

9.4. Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

9.5. Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

9.6. Global Viral Gastroenteritis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

9.7. Global Viral Gastroenteritis Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

9.8. Global Viral Gastroenteritis Market, Sub-Segmentation Of Antimotility Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Loperamide, Diphenoxylate

9.9. Global Viral Gastroenteritis Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

10. Viral Gastroenteritis Market Regional And Country Analysis

10.1. Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Viral Gastroenteritis Market

11.1. Asia-Pacific Viral Gastroenteritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Viral Gastroenteritis Market

12.1. China Viral Gastroenteritis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Viral Gastroenteritis Market

13.1. India Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Viral Gastroenteritis Market

14.1. Japan Viral Gastroenteritis Market Overview

14.2. Japan Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Viral Gastroenteritis Market

15.1. Australia Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Viral Gastroenteritis Market

16.1. Indonesia Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Viral Gastroenteritis Market

17.1. South Korea Viral Gastroenteritis Market Overview

17.2. South Korea Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Viral Gastroenteritis Market

18.1. Taiwan Viral Gastroenteritis Market Overview

18.2. Taiwan Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Viral Gastroenteritis Market

19.1. South East Asia Viral Gastroenteritis Market Overview

19.2. South East Asia Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Viral Gastroenteritis Market

20.1. Western Europe Viral Gastroenteritis Market Overview

20.2. Western Europe Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Viral Gastroenteritis Market

21.1. UK Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Viral Gastroenteritis Market

22.1. Germany Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Viral Gastroenteritis Market

23.1. France Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Viral Gastroenteritis Market

24.1. Italy Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Viral Gastroenteritis Market

25.1. Spain Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Viral Gastroenteritis Market

26.1. Eastern Europe Viral Gastroenteritis Market Overview

26.2. Eastern Europe Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Viral Gastroenteritis Market

27.1. Russia Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Viral Gastroenteritis Market

28.1. North America Viral Gastroenteritis Market Overview

28.2. North America Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Viral Gastroenteritis Market

29.1. USA Viral Gastroenteritis Market Overview

29.2. USA Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Viral Gastroenteritis Market

30.1. Canada Viral Gastroenteritis Market Overview

30.2. Canada Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Viral Gastroenteritis Market

31.1. South America Viral Gastroenteritis Market Overview

31.2. South America Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Viral Gastroenteritis Market

32.1. Brazil Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Viral Gastroenteritis Market

33.1. Middle East Viral Gastroenteritis Market Overview

33.2. Middle East Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Viral Gastroenteritis Market

34.1. Africa Viral Gastroenteritis Market Overview

34.2. Africa Viral Gastroenteritis Market, Segmentation By Drugs, Segmentation By Diagnosis, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Viral Gastroenteritis Market Regulatory and Investment Landscape

36. Viral Gastroenteritis Market Competitive Landscape And Company Profiles

36.1. Viral Gastroenteritis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Viral Gastroenteritis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Viral Gastroenteritis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi S A Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

37. Viral Gastroenteritis Market Other Major And Innovative Companies

Mylan N V, Dr Reddys Laboratories Ltd, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, ANI Pharmaceuticals Inc, Merck Sharp & Dohme Corp, Abbvie Inc, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Roche Holding AG, BristolMyersSquibb Company, Amgen Inc, Eli Lilly and Company

38. Global Viral Gastroenteritis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Viral Gastroenteritis Market

40. Viral Gastroenteritis Market High Potential Countries, Segments and Strategies

40.1 Viral Gastroenteritis Market In 2030 - Countries Offering Most New Opportunities

40.2 Viral Gastroenteritis Market In 2030 - Segments Offering Most New Opportunities

40.3 Viral Gastroenteritis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Viral Gastroenteritis Market, Overview Of Key Products - Product Examples

Table 2: Global Viral Gastroenteritis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Viral Gastroenteritis Market, Supply Chain Analysis

Table 4: Global Viral Gastroenteritis Market, Major Raw Material Providers

Table 5: Global Viral Gastroenteritis Market, Major Resource Providers

Table 6: Global Viral Gastroenteritis Market, Major Manufacturers (Suppliers)

Table 7: Global Viral Gastroenteritis Market, Major Distributors And Channel Partners

Table 8: Global Viral Gastroenteritis Market, Key Technologies & Future Trends

Table 9: Global Viral Gastroenteritis Market, Major Trends

Table 10: Global Viral Gastroenteritis Market, Major End Users

Table 11: Global Viral Gastroenteritis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Viral Gastroenteritis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Viral Gastroenteritis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Viral Gastroenteritis Market - TAM, US$ Billion, 2025

Table 15: Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antimotility Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Viral Gastroenteritis Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Viral Gastroenteritis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Viral Gastroenteritis Market - Company Scoring Matrix

Table 100: Pfizer Inc. Financial Performance

Table 101: Sanofi S A Financial Performance

Table 102: Abbott Laboratories Financial Performance

Table 103: GlaxoSmithKline Plc Financial Performance

Table 104: Takeda Pharmaceutical Company Limited Financial Performance

Table 105: Global Viral Gastroenteritis Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Viral Gastroenteritis Market, Competitive Dashboard

Table 107: Global Viral Gastroenteritis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Viral Gastroenteritis Market Size Gain ($ Billion), Segmentation By Drugs, 2025 – 2030

Table 109: Global, Viral Gastroenteritis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 110: Global, Viral Gastroenteritis Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

Figure 1: Global Viral Gastroenteritis Market, Overview Of Key Products - Product Examples

Figure 2: Global Viral Gastroenteritis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Viral Gastroenteritis Market, Supply Chain Analysis

Figure 4: Global Viral Gastroenteritis Market, Major Raw Material Providers

Figure 5: Global Viral Gastroenteritis Market, Major Resource Providers

Figure 6: Global Viral Gastroenteritis Market, Major Manufacturers (Suppliers)

Figure 7: Global Viral Gastroenteritis Market, Major Distributors And Channel Partners

Figure 8: Global Viral Gastroenteritis Market, Key Technologies & Future Trends

Figure 9: Global Viral Gastroenteritis Market, Major Trends

Figure 10: Global Viral Gastroenteritis Market, Major End Users

Figure 11: Global Viral Gastroenteritis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Viral Gastroenteritis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Viral Gastroenteritis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Viral Gastroenteritis Market - TAM, US$ Billion, 2025

Figure 15: Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antimotility Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Viral Gastroenteritis Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Viral Gastroenteritis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Viral Gastroenteritis Market - Company Scoring Matrix

Figure 100: Pfizer Inc. Financial Performance

Figure 101: Sanofi S A Financial Performance

Figure 102: Abbott Laboratories Financial Performance

Figure 103: GlaxoSmithKline Plc Financial Performance

Figure 104: Takeda Pharmaceutical Company Limited Financial Performance

Figure 105: Global Viral Gastroenteritis Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Viral Gastroenteritis Market, Competitive Dashboard

Figure 107: Global Viral Gastroenteritis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Viral Gastroenteritis Market Size Gain ($ Billion), Segmentation By Drugs, 2025 – 2030

Figure 109: Global, Viral Gastroenteritis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 110: Global, Viral Gastroenteritis Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Key Developments and Trends Steering the Narcolepsy Market Forward: Development Of Extended-Release Medications In The Narcolepsy Market

Major Trends and Emerging Patterns in the Narcolepsy Drugs Market: Advancements In Extended-Release Therapeutics Revolutionize Narcolepsy Treatment

Key Factors Fueling the Growth of the Needle-Free Drug Delivery Devices Market in 2025: Diabetes As A Catalyst Is Driving Growth In The Needle-Free Drug Delivery Devices Market

Critical Market Drivers Shaping the Outlook for Neurocognitive Assessment And Rehabilitation Market from 2025-2034: Rising Prevalence Of Neurological Disorders Fuels Growth In Neurocognitive Assessment And Rehabilitation Market

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report 2026 - Global Outlook – By Type (Capping Agents, Nucleotides, Plasmid DNA, Other Types), By Applications (Therapeutics Production, Vaccine Productio...

Retort Machine Market Report 2026 - Global Outlook – By Process (Batch Sterilization, Continuous Sterilization), By Type (Saturated Steam, Water Immersion, Water Spray, Forced Steam Or Air), By End User (Food And Beverag...

Workstation Software Market Report 2026 - Global Outlook – By Type (Image And Video Processing Software, Virtual Reality Software, Computer Aided Design (CAD), Computer Aided Manufacturing (CAM), Computer Aided Engineeri...

Toluene Derivatives Market Report 2026 - Global Outlook – By Type (Benzene, Xylene, Toluene Diisocyanate (TDI), Other Types), By Production Process (Selective Toluene Disproportionation, Transalkylation, Hydrodealkylatio...

Automotive Performance Tuning And Engine Remapping Services Market Report 2026 - Global Outlook – By Service Type (Engine Performance Tuning, ECU Remapping And Reprogramming, Transmission Control Unit (TCU) Tuning, Dyno ...

Viral Vector Manufacturing Market Report 2026 - Global Outlook – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, I...

Frequently Asked Questions

How big is the Viral Gastroenteritis Market?

The Viral Gastroenteritis market was valued at $7.06 billion in 2025, increased to $7.43 billion in 2026, and is projected to reach $9.2 billion by 2030.

What is the Viral Gastroenteritis market growth?

The global Viral Gastroenteritis market is expected to grow at a CAGR of 5.5% from 2026 to 2035 to reach $9.2 billion by 2035.

Who are the key players in Viral Gastroenteritis market?

Some Key Players in the Viral Gastroenteritis market Include, Pfizer Inc., Sanofi S A, Abbott Laboratories, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Mylan N V, Dr Reddys Laboratories Ltd, Lupin Limited, Zydus Lifesciences Limited, A

Major trend in this market includes: Innovative PCR Kits Reshaping The Viral Gastroenteritis Market. For further insights on this market. request a sample here

North America was the largest region in the viral gastroenteritis market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacif

Book your 30 minutes free consultation with our research experts

Contact Us